share_log

长春高新(000661.SZ):黄体酮注射液(Ⅱ)纳入国家医保目录

Changchun high-tech industries (000661.SZ): Progesterone injection (II) included in the national medical insurance directory.

Gelonghui Finance ·  Nov 28 17:17

Changchun High-Tech Industries (000661.SZ) announced on November 28th that, according to the notice issued by the National Medical Insurance Administration and the Ministry of Human Resources and Social Security on the issuance of the 2024 National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog (Medical Insurance Development [2024] No. 33), Changchun High-Tech Industries (Group) Co., Ltd., a holding subsidiary of Changchun Jinsai Pharmaceutical Co., Ltd., has included Jinsai Xin Progesterone Injection (Ⅱ) (1.112ml:25mg) in the 2024 National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalog.

The inclusion of Jinsai Xin Progesterone Injection (Ⅱ) in the 2024 National Medical Insurance Catalog marks Jinsai Xin Progesterone Injection (Ⅱ) as the first nationally negotiated pharmaceutical product in the field of assisted reproduction.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment